Dr. Cory Lemoine, DO
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,418 | 149 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $462.36 | 30 | $0 (2024) |
| PFIZER INC. | $414.64 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $274.79 | 15 | $0 (2024) |
| ABBVIE INC. | $171.01 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $144.59 | 10 | $0 (2024) |
| Exact Sciences Corporation | $125.68 | 7 | $0 (2024) |
| Novo Nordisk Inc | $120.21 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $107.83 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.60 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $85.32 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $711.10 | 39 | Lilly USA, LLC ($101.09) |
| 2023 | $726.09 | 43 | Lilly USA, LLC ($214.21) |
| 2022 | $367.79 | 23 | Lilly USA, LLC ($123.11) |
| 2021 | $434.64 | 32 | PFIZER INC. ($209.07) |
| 2020 | $145.87 | 10 | PFIZER INC. ($119.52) |
| 2019 | $32.76 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16.65) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Diabetes | ||||||
| 11/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Biological | ||||||
| 10/15/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Biological | ||||||
| 07/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes Care | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: ADHD | ||||||
| 05/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/23/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: ADHD | ||||||
| 05/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Endocrinology | ||||||
| 05/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 367 | 496 | $72,308 | $31,416 |
| 2022 | 11 | 426 | 553 | $89,978 | $36,840 |
| 2021 | 14 | 475 | 699 | $98,719 | $41,909 |
| 2020 | 10 | 311 | 379 | $62,960 | $23,225 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 170 | $35,020 | $12,552 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $11,840 | $7,724 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 110 | $15,400 | $6,126 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,332 | $1,579 | 67.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,312 | $1,180 | 35.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $1,387 | $739.80 | 53.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $966.00 | $666.77 | 69.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $462.00 | $318.89 | 69.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 33 | $1,188 | $314.16 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 32 | $401.00 | $215.88 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 180 | $37,080 | $13,376 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 56 | 56 | $11,270 | $7,051 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 121 | $16,940 | $6,724 | 39.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $11,880 | $4,781 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $6,072 | $1,686 | 27.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 22 | $2,332 | $1,482 | 63.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 24 | $1,008 | $660.72 | 65.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $798.00 | $521.32 | 65.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 36 | $1,296 | $345.25 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 40 | 43 | $714.00 | $127.59 | 17.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 12 | $588.00 | $86.89 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 241 | $49,646 | $19,891 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 51 | 51 | $12,750 | $6,569 | 51.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 75 | $10,500 | $5,131 | 48.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 36 | 36 | $7,624 | $4,485 | 58.8% |
About Dr. Cory Lemoine, DO
Dr. Cory Lemoine, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Broussard, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760836597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cory Lemoine, DO has received a total of $2,418 in payments from pharmaceutical and medical device companies, with $711.10 received in 2024. These payments were reported across 149 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,418).
As a Medicare-enrolled provider, Lemoine has provided services to 1,579 Medicare beneficiaries, totaling 2,127 services with total Medicare billing of $133,391. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Broussard, LA
- Active Since 04/18/2016
- Last Updated 03/14/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1760836597
Products in Payments
- MOUNJARO (Drug) $239.08
- COLOGUARD DNA CAPTURE REAGENTS (Device) $209.07
- JARDIANCE (Drug) $177.58
- SHINGRIX (Biological) $175.72
- VRAYLAR (Drug) $143.50
- Cologuard Collection Kit (Device) $125.68
- FARXIGA (Drug) $111.63
- TRULICITY (Drug) $94.56
- TRINTELLIX (Drug) $85.32
- Otezla (Drug) $84.56
- TRELEGY ELLIPTA (Drug) $82.96
- Veozah (Drug) $80.86
- Ozempic (Drug) $67.62
- COLOGUARD (Device) $62.90
- CHANTIX (Drug) $56.62
- Rybelsus (Drug) $52.59
- FREESTYLE LIBRE 3 (Device) $52.05
- SOLIQUA 100/33 (Biological) $42.77
- EMGALITY (Drug) $38.74
- JORNAY PM (Drug) $36.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Broussard
Margaret Hebert
Student in an Organized Health Care Education/Training Program — Payments: $1,918
Madison Ackel, Dds, DDS
Student in an Organized Health Care Education/Training Program